Groups representing a range of health groups including BCAC explained the urgent need for funding for important medicines. A united voice was presented. Moving photos of BCAC members and representatives of other groups.
New Zealand’s Breast Special Interest Group (BSIG) has written to the Health Select Committee saying many breast cancer patients who can’t afford to pay for certain medicines themselves have shorter lives and poorer quality of life.
The committee is considering two petitions from Metavivors calling for the funding of two medicines for advanced breast cancer – Ibrance and Kadcyla.
The submission is signed by BSIG group chair Dr Reuben Broom and secretary Dr Sarah Barton, and calls for more money for PHARMAC to give those with breast cancer more treatment options at affordable prices.
Malcolm Mulholland, who wrote the letter calling for a review of PHARMAC that was presented to Parliament, expresses his extreme disappointment the review request has been turned down. Health Minister David Clark shares his views, which BCAC do not agree with.
